Ipamorelin vs CJC-1295: Which Growth Hormone Peptide?
They are often mentioned together, but Ipamorelin and CJC-1295 work in different ways. A research comparison of the two most popular growth-hormone peptides.
Two Different Tools
Ipamorelin and CJC-1295 are the two most discussed growth-hormone peptides in research, and they are frequently paired. Understanding why means understanding that they act through different mechanisms.
CJC-1295: A GHRH Analogue
CJC-1295 is an analogue of growth-hormone-releasing hormone (GHRH). It has been studied for signalling the pituitary to produce and release growth hormone, raising the baseline of GH output over a sustained window.
Ipamorelin: A Selective Secretagogue
Ipamorelin works on a different receptor — the ghrelin receptor — and is studied as a growth-hormone secretagogue. It is valued in research for being selective: it has been examined for stimulating GH release without the cortisol or prolactin elevation seen with some other secretagogues.
Side by Side
| Feature | CJC-1295 (no DAC) | Ipamorelin |
|---|---|---|
| --- | --- | --- |
| Class | GHRH analogue | GH secretagogue |
| Receptor | GHRH receptor | Ghrelin receptor |
| Studied for | Sustained GH signalling | Selective GH pulse |
Why They Are Stacked
Because they act on two separate receptors, research interest lies in combining them: CJC-1295 raises how much GH the pituitary is prepared to release, while Ipamorelin triggers the release itself. This is why the two are offered pre-combined — see the CJC-1295 + Ipamorelin blend at peptidesandyou.com/product/cjc-1295-no-dac-ipamorelin, and our peptide stacking guide for the wider context.
Availability at Peptides & You
Both peptides, and the combination, are available as lab-tested vials with Janoshik Certificates of Analysis. Review the results at peptidesandyou.com/lab-results.
For laboratory and research use only. Not for human or veterinary consumption. These statements have not been evaluated by the U.S. FDA or the Philippine FDA.